Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
PLoS One ; 19(3): e0301397, 2024.
Article in English | MEDLINE | ID: mdl-38547222

ABSTRACT

Hepatitis A virus (HAV) infection has disproportionately affected more men who have sex with men (MSM), occurring in outbreaks, despite being vaccine-preventable. We determined the prevalence and factors associated with HAV susceptibility among cisgender MSM on HIV pre-exposure prophylaxis (PrEP) in Northeastern Brazil. From September 30, 2021 to June 19, 2023, 282 cisgender MSM receiving HIV PrEP were enrolled into this cross-sectional study. Sociodemographic and clinical information were collected. Blood samples were collected for screening of sexually transmitted infections (STIs) and serum samples were tested for IgM and total anti-HAV antibodies. Non-reactive results for total anti-HAV antibodies were found in 106 of 282 (37.6%) participants. Factors associated with HAV susceptibility included age <30 years (prevalence ratio [PR]: 2.02; 95% confidence interval [95% CI]: 1.61-2.53), having health insurance (PR: 1.39; 95% CI: 1.19-1.64), sex only with cisgender men (PR: 1.52; 95% CI: 1.23-1.89), non-steady partner (PR: 1.20; 95% CI: 1.01-1.43) and no lifetime history of STIs (PR: 1.25; 95% CI: 1.03-1.53). Identifying clinical correlates of HAV susceptibility in key populations is a fundamental step towards development of public policy focused on prevention, especially following the recent hepatitis A outbreak in Brazil.


Subject(s)
HIV Infections , Hepatitis A virus , Hepatitis A , Pre-Exposure Prophylaxis , Sexual and Gender Minorities , Sexually Transmitted Diseases , Male , Humans , Adult , Homosexuality, Male , Hepatitis A/epidemiology , Hepatitis A/prevention & control , HIV Infections/epidemiology , HIV Infections/prevention & control , Pre-Exposure Prophylaxis/methods , Cross-Sectional Studies , Hepatitis A Antibodies , Brazil/epidemiology , Sexually Transmitted Diseases/epidemiology , Sexually Transmitted Diseases/prevention & control
2.
J Appl Gerontol ; 40(6): 571-581, 2021 06.
Article in English | MEDLINE | ID: mdl-33406963

ABSTRACT

OBJECTIVE: Analyzing the survival of older people hospitalized due to COVID-19 in Brazil and identifying its main predictive factors for death. METHOD: This is a retrospective, multicenter cohort study, based on 20,831 records of hospitalizations of older people due to SARS-CoV-2 in Brazil. The observation period was from February 28 to May 18, 2020. RESULTS: There was a reduced overall survival time of 47.70% (95% confidence interval [CI] = [46.72%, 48.67%]) in 10 days. The variables age, race, education, intensive care unit (ICU), region, day of hospitalization, time elapsed between the first symptom and hospitalization, and the municipality that provided assistance showed increased risk of death using the multiple Cox proportional-hazards model. CONCLUSION: These results emphasize the relevance of inequality and access to health services as determinants for the death of older people with COVID-19.


Subject(s)
COVID-19/mortality , COVID-19/therapy , Hospitalization/statistics & numerical data , Intensive Care Units/statistics & numerical data , Aged , Aged, 80 and over , Brazil/epidemiology , COVID-19 Testing , Female , Hospital Mortality , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Risk Factors , SARS-CoV-2 , Survival Analysis
3.
Article in English | MEDLINE | ID: mdl-33331521

ABSTRACT

COVID-19 is a viral disease caused by SARS-CoV-2 that compromises the host immune response in severe cases, promoting a hyperinflammation that results in acute lung injury and multiple organs failure. In this context, patients presenting with immune-related diseases, such as Crohn's disease, affected by COVID-19, may have an uncertain prognosis. We report on a case of a young female patient with a severe Crohn's disease that presented with COVID-19 pneumonia and a favorable outcome even maintaining the use of adalimumab, TNF - alpha inhibitor and prednisone. This case raises the hypothesis that aside from prednisone, TNF-α inhibitors such as adalimumab could be used to stop the progression to COVID-19 complications by blocking the TNF-alpha-driven inflammatory process that occurs in severe COVID-19.


Subject(s)
Adalimumab/therapeutic use , COVID-19 , Crohn Disease/drug therapy , Prednisone/therapeutic use , Crohn Disease/virology , Female , Humans , Tumor Necrosis Factor Inhibitors/therapeutic use
4.
Article in English | MEDLINE | ID: mdl-33263701

ABSTRACT

Skins infections caused by Mycobacterium marinum occur only rarely. We report one case of chronic and extensive M. marinum cutaneous infection simulating chromoblastomycosis and review the pertinent literature. A 52-year-old farmer reported a 32-year chronic skin problem on his right lower limb, resulting from contact with cacti. It consisted of skin lesion presenting with dyschromic atrophic center plate and verrucous borders with hematic crusts, extending from the knee anteriorly to the inferior third of the right leg. Mycobacterium marinum infection was detected by histopathological examination of a skin fragment, culture for mycobacteria and genetic mapping of the culture material. The patient was successfully treated with Ethambutol, Rifampicin and Trimethoprim-Sulfamethoxazole. The clinical and histopathological findings of M. marinum infection is nonspecific showing clinical polymorphism and bacilli are rarely evident on histopathological examination. Given these difficulties, it is essential to perform tissue culture in a suspicious case and it is important keep this infection in mind in patients with long-lasting indolent verrucous lesions and a history of exposure to sea water, freshwater, aquaria or fish.


Subject(s)
Chromoblastomycosis/diagnosis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium marinum/isolation & purification , Animals , Chromoblastomycosis/drug therapy , Ethambutol/therapeutic use , Humans , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/drug therapy , Rifampin/therapeutic use , Skin/pathology , Treatment Outcome , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
5.
Rev Inst Med Trop Sao Paulo ; 62: e63, 2020 Sep 04.
Article in English | MEDLINE | ID: mdl-32901760

ABSTRACT

In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause of a cluster of pneumonia cases in China, and the corresponding disease was designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world resulting in a pandemic. COVID-19 is associated with a set of coagulation abnormalities that increase the risk of thromboembolic events, especially in patients with severe/critical disease. We describe a series of five cases of mild COVID-19, treated in an outpatient clinic, which, after an apparent clinical improvement, developed acute pulmonary embolism (APE) between the third and the fourth week after the onset of symptoms, when they are mostly related to acute illness disappearance. Thromboembolic events are also a potential complication of mild COVID-19 and can manifest later in the disease course. This finding raises discussion about the prevention of thromboembolic events in selected group of patients with mild COVID-19.


Subject(s)
Coronavirus Infections/complications , Pneumonia, Viral/complications , Pulmonary Embolism/virology , Acute Disease , Adult , Betacoronavirus , Brazil , COVID-19 , Humans , Male , Middle Aged , Pandemics , Pulmonary Embolism/diagnosis , SARS-CoV-2
6.
Am J Trop Med Hyg ; 102(2): 268-273, 2020 02.
Article in English | MEDLINE | ID: mdl-31872796

ABSTRACT

In immunocompromised patients, visceral leishmaniasis (VL) can present with atypical clinical symptoms that include poor response to treatment. No optimal therapeutic regimen is available for such cases. In a splenectomized male patient, we observed a disseminated form of the disease in the liver, bone marrow, lymph nodes, and gastrointestinal tract. There was an apparent clinical improvement when he was initially treated with liposomal amphotericin B (L-AmB), but this was followed by a relapse involving severe clinical symptoms. He was finally treated successfully with a combination of L-AmB, meglumine antimoniate, and pentamidine isethionate. It is important to include asplenia as an immunosuppressive condition that induces exotic VL pathologies. In such cases, combination anti-Leishmania drug therapy should be considered.


Subject(s)
Amphotericin B/therapeutic use , Leishmaniasis, Visceral/drug therapy , Meglumine Antimoniate/therapeutic use , Pentamidine/therapeutic use , Splenectomy , Amphotericin B/administration & dosage , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/therapeutic use , Bone Marrow/parasitology , Drug Therapy, Combination , Humans , Immunocompromised Host , Intestinal Mucosa/parasitology , Leishmaniasis, Visceral/immunology , Lymph Nodes/parasitology , Male , Meglumine Antimoniate/administration & dosage , Middle Aged , Pentamidine/administration & dosage
7.
BMC Infect Dis ; 19(1): 220, 2019 Mar 04.
Article in English | MEDLINE | ID: mdl-30832607

ABSTRACT

BACKGROUND: Cryptococcosis is a common opportunistic infection in patients infected by Human Immunodeficiency Virus (HIV) and is the second leading cause of mortality in Acquired Immunodeficiency Syndrome (AIDS) patients worldwide. The most frequent presentation of cryptococcal infection is subacute meningitis, especially in patients with a CD4+ T Lymphocytes count below 100 cells/µL. However, in severely immunosuppressed individuals Cryptococcus neoformans can infect virtually any human organ, including the bone marrow, which is a rare presentation of cryptococcosis. CASE PRESENTATION: A 45-year-old HIV-infected male patient with a CD4+ T lymphocyte count of 26 cells/µL who presented to the emergency department with fever and pancytopenia. Throughout the diagnostic evaluation, the bone marrow aspirate culture yielded encapsulated yeasts in budding, identified as Cryptococcus sp. The bone marrow biopsy revealed a hypocellularity for age and absence of fibrosis. It was observed presence of loosely formed granuloma composed of multinucleated giant cells encompassing rounded yeast like organisms stained with mucicarmine, compatible with Cryptococcus sp. Then, the patient underwent a lumbar puncture to investigate meningitis, although he had no neurological symptoms and neurological examination was normal. The cerebrospinal fluid culture yielded Cryptococcus sp. The species and genotype identification step showed the infection was caused by Cryptococcus neoformans var. grubii (genotype VNI). The patient was initially treated with amphotericin B deoxycholate plus fluconazole for disseminated cryptococcosis, according to guideline recommendations. However, the patient developed acute kidney injury and the treatment was switched for fluconazole monotherapy. The symptoms disappeared completely with recovery of white blood cells and platelets counts. Cerebrospinal fluid cultures for fungi at one and two-weeks of treatment were negative. CONCLUSIONS: Bone marrow infection caused by Cryptococcus neoformans is a rare presentation of cryptococcosis. The cryptococcal infection should be included for differential diagnosis in HIV-infected patients with fever and cytopenias, especially when CD4+ T lymphocytes count is below 100 cells/µL.


Subject(s)
Bone Marrow/microbiology , Cryptococcosis/diagnosis , Cryptococcus neoformans/isolation & purification , HIV Infections/pathology , Acute Kidney Injury/etiology , Amphotericin B/adverse effects , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Bone Marrow/pathology , CD4-Positive T-Lymphocytes/cytology , Cerebrospinal Fluid/microbiology , Cryptococcosis/complications , Cryptococcosis/drug therapy , Cryptococcosis/microbiology , Cryptococcus neoformans/drug effects , Cryptococcus neoformans/genetics , Deoxycholic Acid/adverse effects , Deoxycholic Acid/pharmacology , Deoxycholic Acid/therapeutic use , Diagnosis, Differential , Drug Combinations , Fluconazole/pharmacology , Fluconazole/therapeutic use , Genotype , HIV Infections/complications , Humans , Male , Meningitis/complications , Meningitis/diagnosis , Middle Aged
8.
Rev Inst Med Trop Sao Paulo ; 60: e74, 2018 Nov 14.
Article in English | MEDLINE | ID: mdl-30462797

ABSTRACT

Rhodococcus equi is a facultative aerobic, intracellular, non-motile, non-spore-forming, Gram-positive, weakly acid-fast coccobacillus belonging to the group of nocardioform actinomycetes. R. equi infections are rare opportunistic illnesses in patients with Acquired Immunodeficiency Syndrome (AIDS), associated with a high mortality rate. The most common clinical presentation of R. equi infections is a chronic cavitary pneumonia. Due to its acid-fastness, R. equi can be mistaken for others acid-fast organisms, as Mycobacterium tuberculosis. In turn, R. equi is also a gram-positive pleomorphic bacteria and can be mistaken for diphtheroids or Micrococcus organisms, being accidentally disregarded as oral contaminants in sputum cultures. Therefore, in Brazil, a highly prevalent tuberculosis (TB) country, pulmonary infections caused by R. equi may mimic pulmonary TB and represent a diagnostic challenge. Here, we report on a case of chronic cavitary pneumonia by R. equi in a Human Immunodeficiency Virus (HIV)-infected patient, focusing on diagnostic aspects.


Subject(s)
Acquired Immunodeficiency Syndrome/microbiology , Actinomycetales Infections/microbiology , Pneumonia, Necrotizing/microbiology , Rhodococcus equi , Acquired Immunodeficiency Syndrome/diagnosis , Actinomycetales Infections/diagnosis , Chronic Disease , Humans , Male , Middle Aged , Pneumonia, Necrotizing/diagnosis
9.
Open educational resource in Portuguese | CVSP - Brazil | ID: una-3688

ABSTRACT

A vacinação é uma medida exitosa de prevenção primária em termos de custo-eficácia, entretanto, persistem entraves para vacinação infantil nas famílias brasileiras. Este plano de ação é uma atividade educativa sobre vacinação infantil objetivando promover discussão entre docentes, pais e profissionais de saúde. A ação foi dividida em três etapas: discussão sobre vacinação infantil, apresentação do calendário nacional de vacinação e análise dos cartões vacinais dos alunos. Os pais esclareceram suas dúvidas sobre vacinação infantil e consolidaram conhecimentos, permitindo a construção de um saber coletivo sobre o tema. Apresentou-se o calendário nacional de vacinação da criança, possibilitando o empoderamento sobre o calendário vacinal dos filhos. Analisaram-se 60 cartões de vacinas, destes, 16 alunos tinham pendências vacinais, sendo encaminhados à UBS para regularização. A escola é um cenário oportuno para incentivo à vacinação e identificação de pendências vacinais, destacando a intersetorialidade das ações, mediante parcerias com as UBS.


Subject(s)
Vaccination , Health Education , Child Health
SELECTION OF CITATIONS
SEARCH DETAIL
...